Blog
Qualys (QLYS) Earnings Expected to Grow: Should You Buy?
The market expects Qualys (QLYS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is
Par Petroleum (PARR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Wall Street expects a year-over-year decline in earnings on lower revenues when Par Petroleum (PARR) reports results for the quarter ended March 2025. While this widely-known consensus outlook is
Lemonade (LMND) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
The market expects Lemonade (LMND) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is
LCI (LCII) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
LCI (LCII) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a good
Leidos (LDOS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Leidos (LDOS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is
Krystal Biotech, Inc. (KRYS) Earnings Expected to Grow: Should You Buy?
Krystal Biotech, Inc. (KRYS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Jazz Pharmaceuticals (JAZZ) reports results for the quarter ended March 2025. While this widely-known consensus
Will Lucid Group (LCID) Report Negative Earnings Next Week? What You Should Know
Wall Street expects a year-over-year increase in earnings on higher revenues when Lucid Group (LCID) reports results for the quarter ended March 2025. While this widely-known consensus outlook is
Analysts Estimate J&J Snack Foods (JJSF) to Report a Decline in Earnings: What to Look Out for
The market expects J&J Snack Foods (JJSF) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Earnings Preview: IPG Photonics (IPGP) Q1 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on lower revenues when IPG Photonics (IPGP) reports results for the quarter ended March 2025. While this widely-known consensus outlook is
Ingredion (INGR) Earnings Expected to Grow: Should You Buy?
The market expects Ingredion (INGR) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook
Heron Therapeutics (HRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Heron Therapeutics (HRTX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Analysts Estimate International General Insurance Holdings Ltd. (IGIC) to Report a Decline in Earnings: What to Look Out for
Wall Street expects a year-over-year decline in earnings on higher revenues when International General Insurance Holdings Ltd. (IGIC) reports results for the quarter ended March 2025. While this
Intapp (INTA) Earnings Expected to Grow: Should You Buy?
The market expects Intapp (INTA) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is
Forrester Research (FORR) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Wall Street expects a year-over-year decline in earnings on lower revenues when Forrester Research (FORR) reports results for the quarter ended March 2025. While this widely-known consensus outlook
Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Halozyme Therapeutics (HALO) reports results for the quarter ended March 2025. While this widely-known consensus
Will Forge Global Holdings, Inc. (FRGE) Report Negative Q1 Earnings? What You Should Know
Forge Global Holdings, Inc. (FRGE) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known
Will Genius Sports Limited (GENI) Report Negative Earnings Next Week? What You Should Know
Genius Sports Limited (GENI) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Analysts Estimate Helios Technologies (HLIO) to Report a Decline in Earnings: What to Look Out for
Wall Street expects a year-over-year decline in earnings on lower revenues when Helios Technologies (HLIO) reports results for the quarter ended March 2025. While this widely-known consensus outlook
Analysts Estimate Esperion Therapeutics (ESPR) to Report a Decline in Earnings: What to Look Out for
The market expects Esperion Therapeutics (ESPR) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known
Expeditors International (EXPD) Earnings Expected to Grow: Should You Buy?
The market expects Expeditors International (EXPD) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known
Enlight Renewable Energy Ltd. (ENLT) Earnings Expected to Grow: Should You Buy?
The market expects Enlight Renewable Energy Ltd. (ENLT) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This
Analysts Estimate Datadog (DDOG) to Report a Decline in Earnings: What to Look Out for
The market expects Datadog (DDOG) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is
Earnings Preview: Fortune Brands Innovations (FBIN) Q1 Earnings Expected to Decline
The market expects Fortune Brands Innovations (FBIN) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known
Coty (COTY) Reports Next Week: What You Should Expect
Coty (COTY) is expected to deliver flat earnings compared to the year-ago quarter on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook